Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world’s #1 AI CRM, today announced that Haleon will leverage Salesforce ...

[Le Maine Libre] Du mardi 4 au jeudi 6 novembre, Maine Sciences en collaboration avec l’Établissement Public Territorial du ...

Les croyances que l’on entretient sur l’intelligence modèlent nos manières d’apprendre, avec des conséquences directes sur la ...

Our Life Sciences Masters™ 2024 program will focus on the intersection of intellectual property and the biopharmaceutical industry. With topics covering the innovation ecosystem, the PTO Terminal ...

Our Fourth Annual Life Sciences Masters™ 2025 program will focus on the intersection of intellectual property and the biopharmaceutical industry, and will explore the law, politics, and business of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Wilmington company backed by ...

One of the paradoxes of religious and intellectual life is the tension between continuity and change. On the one hand, communities - particularly religious ones - hunger for certainty. The ordinary ...

The new 45,000-square-foot Health Sciences Building at Elmhurst University opened Oct. 3 amid ribbon-cutting pomp. The state-of-the-art facility now houses the Departments of Nursing, Public Health, ...

Two former Wilmer lawyers joined Cooley's life sciences licensing and corporate partnership practice this week. Cooley also hired a former Sidley Austin lawyer as a partner in its San Francisco office ...

Face à l'urgence climatique, la géo-ingénierie climatique, ensemble de techniques visant à modifier intentionnellement le climat de la Terre afin d'en limiter le réchauffement global, est apparue ...

Gilead Sciences, Inc. (NASDAQ:GILD) announced Monday that it has entered into settlement agreements to resolve patent litigation with generic pharmaceutical companies Lupin Ltd., Cipla Ltd., and ...

Unveiled at BioTechX Europe 2025, the new solutions are purpose-built to accelerate research, clinical trial design and regulatory processes. EIX-Submission Readiness empowers teams to build smarter, ...